PDK1-IN-1

• UNSPSC Description:

  PDK1-IN-1 (Compound 2-11) is a PDK1 inhibitor, and can be used for research of myeloproliferative disorders or cancer[1].

• Target Antigen:

  PDK-1

• Type:

  Reference compound

• Related Pathways:

  PI3K/Akt/mTOR

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/pdk1-in-1.html

• Purity:

  99.95

• Solubility:

  DMSO : 10 mg/mL (ultrasonic;warming;heat to 60°C)

• Smiles:

  BrC1=CN2C(C(OC)=C1)=C(C=N2)C#N

• Molecular Weight:

  252.071

• References & Citations:

  [1]Jason Katz, et al. Therapeutic compounds. Patent. WO2010017047 A1

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  1207836-10-9